Showing results (441-450 of 612) with videos related to

Sort By:
Pageof 62
Multiple Sclerosis Journal - Experimental, Translational and Clinical|July 24, 2023
Multiple sclerosis and ulcerative colitis: A systematic review and meta-analysisFardin Nabizadeh, Ali Azizi, Lina Hejrati, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 28, 2023
Hypogammaglobulinemia secondary to B-cell depleting therapies in neuroimmunology: Comparing management strategiesHannah Kelly, Anastasia Vishnevetsky, Lori B Chibnik, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 2, 2023
Health-economic benefits of anti-CD20 treatments in relapsing multiple sclerosis estimated using a treatment-sequence modelIde Smets, Matthijs Versteegh, Simone Huygens, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|July 24, 2023
Pain and participation in social activities in people with relapsing remitting and progressive multiple sclerosisDhruv Jain, Charles N Bernstein, Lesley A Graff, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|July 9, 2026
Ocular-motor conduction dynamics and variability in multiple sclerosis-related internuclear ophthalmoparesis: A randomized dalfampridine trialAlessandro Serra, Clara Chisari, Jonathan B Jacobs, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 30, 2026
Characteristics of myelin oligodendrocyte glycoprotein antibody-associated meningoencephalitisAisha Elfasi, Samir Alkabie, Elsa Rodriguez, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 10, 2026
Sex-dependent bioactive lipid mediator profiles in multiple sclerosisWing Hee Fung, Serhii Chornyi, Menno M Schoonheim, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|July 25, 2026
Circulating microRNA expression profiles as biomarkers of disease activity in multiple sclerosisIfat Vigiser, Yoav Zeevi, Yoav Piura, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|July 23, 2026
Establishing demographic-based normative values for neurofilament light chain and glial fibrillary acidic protein in serum and plasma samplesTyler L Borko, Alanna Ritchie, Sean Selva, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 23, 2026
Assessing the feasibility, theoretical interest, and observed behaviors of adding genetic data to a patient-reported multiple sclerosis registryKaarina Kowalec, Douglas Menendez, Gary Cutter, et al.
Pageof 62